Bandy-Plus

Product Overview

Bandy-Plus is a dual-action antiparasitic medication combining Ivermectin and Albendazole. This synergistic formulation provides broad-spectrum treatment against various parasitic infestations, including intestinal worms and ectoparasites. The medication effectively eliminates parasites while alleviating associated symptoms and promoting recovery.

Indications

Bandy-Plus is indicated for the treatment of:

• Ascariasis (roundworm infection caused by Ascaris lumbricoides)
• Hookworm infections (Ancylostoma duodenale and Necator americanus)
• Strongyloidiasis (threadworm infection by Strongyloides stercoralis)
• Onchocerciasis (river blindness caused by Onchocerca volvulus)

The medication demonstrates high efficacy against both adult parasites and their larval forms.

Administration Guidelines

For optimal results:

• Take orally with water during or after meals to enhance bioavailability
• Swallow tablets whole without crushing or chewing
• Dosage varies based on infection type, severity, and patient parameters
• Strictly adhere to prescribed dosing regimen

Mechanism of Action

The combined pharmacological action provides superior antiparasitic effects:

• Ivermectin: Induces paralysis by potentiating glutamate-gated chloride channels in parasite nerve cells
• Albendazole: Inhibits microtubule polymerization, disrupting cellular glucose uptake and energy metabolism

This dual mechanism ensures comprehensive parasite eradication.

Dosage Protocol

Treatment regimen involves:

• Single or multiple doses as clinically indicated
• Weight-adjusted dosing for pediatric patients
• Complete prescribed course even with symptom resolution
• Possible retreatment for certain chronic infections

Therapeutic Advantages

• Broad-spectrum antiparasitic coverage
• High cure rates for multiple helminthic infections
• Symptomatic relief from gastrointestinal distress
• Convenient oral dosage form
• Favorable safety profile

Adverse Effects

Common transient reactions may include:

• Gastrointestinal disturbances (nausea, abdominal discomfort)
• CNS effects (mild dizziness, headache)
• Allergic skin reactions in sensitive individuals

Persistent or severe reactions warrant medical attention.

Precautions

Important safety considerations:

• Disclose all concomitant medications (including supplements)
• Contraindicated in pregnancy (Category C) unless clearly needed
• Exercise caution in hepatic impairment
• Avoid alcohol consumption during therapy
• Monitor for Mazzotti reactions in onchocerciasis treatment

Storage Conditions

Proper storage requirements:

• Maintain at 15-30°C in original packaging
• Protect from moisture and direct sunlight
• Keep securely closed and out of children’s reach
• Discard expired medication properly

Medical Disclaimer

This information serves educational purposes only and does not constitute medical advice. While we strive for accuracy, the content may not encompass all potential drug interactions or contraindications. Always consult your healthcare provider for personalized medical guidance. This information supplements but does not replace professional medical consultation.